Institution
Medical City Dallas Hospital
Healthcare•Dallas, Texas, United States•
About: Medical City Dallas Hospital is a healthcare organization based out in Dallas, Texas, United States. It is known for research contribution in the topics: Aortic valve replacement & Percutaneous coronary intervention. The organization has 195 authors who have published 259 publications receiving 15587 citations.
Topics: Aortic valve replacement, Percutaneous coronary intervention, Coronary artery disease, Coronary artery bypass surgery, Conventional PCI
Papers published on a yearly basis
Papers
More filters
••
University of Michigan1, National University of Singapore2, University of Toronto3, Utah System of Higher Education4, Boston Children's Hospital5, Medical City Dallas Hospital6, Extracorporeal Life Support Organization7, Baylor College of Medicine8, NewYork–Presbyterian Hospital9, Central Texas College10, University of Paris11
TL;DR: In patients with COVID-19 who received ECMO, both estimated mortality 90 days after ECMO and mortality in those with a final disposition of death or hospital discharge were less than 40%.
655 citations
••
Medical City Dallas Hospital1, Johns Hopkins University2, Johns Hopkins University School of Medicine3, Stanford University4, University of Texas Health Science Center at Houston5, University of Rochester Medical Center6, Tufts University7, University of British Columbia8, Baylor College of Medicine9
TL;DR: This review presents the definition and 5-stage classification system of CKD developed by the work group assigned to develop the guidelines, and summarizes the major recommendations regarding the early detection of CKd.
Abstract: Objectives. A series of new guidelines has been developed by the National Kidney Foundation’s Kidney Disease Outcomes Quality Initiative to improve the detection and management of chronic kidney disease (CKD). In most instances of CKD, the earliest manifestations of the disorder may be identified by relatively simple tests. Unfortunately, CKD is often “underdiagnosed,” in part because of the absence of a common definition of CKD and a classification of the stages in its progression. The Kidney Disease Outcomes Quality Initiative clinical practice guidelines for CKD evaluation, classification, and stratification provide a basis to remedy these deficits. The specific goals of the guidelines described in this review are to provide: 1) an overview of the clinical practice guidelines as they pertain to children and adolescents, 2) a simple classification of the stages of CKD, and 3) a practical approach to the laboratory assessment of kidney disease in children and adolescents. Methods. The guidelines were developed as part of an evidence-based evaluation of CKD and its consequences in patients of all ages. The data that were used to generate the guidelines in this article were extracted from a structured analysis of articles that reported on children with CKD. Results and Conclusions. This review presents the definition and 5-stage classification system of CKD developed by the work group assigned to develop the guidelines, and summarizes the major recommendations regarding the early detection of CKD. Major emphasis is placed on the identification of children and adolescents with CKD by measuring the protein-to-creatinine ratio in spot urine specimens and by estimating the glomerular filtration rate from serum creatinine using prediction equations.
631 citations
••
TL;DR: The timing of retinal vascular events correlated more closely with postconceptional age than with postnatal age, implicating the level of maturity more than postnatal environmental influences in governing the timing of these vascular events.
613 citations
••
TL;DR: The SYNTAX score is a visual coronary score with an acceptable corelab reproducibility that has an impact on the one-year outcome of those having PCI, whereas it has no effect on theOne- year outcome following surgical revascularisation.
Abstract: Aims: The SYNTAX™ score has been designed to better anticipate the risks of percutaneous or surgical revascularisation, taking into account the functional impact of the coronary circulation with all its anatomic components including the presence of bifurcations, total occlusions, thrombus, calcification, and small vessels. The purpose of this paper is to describe the baseline assessment of the SYNTAX™ score in the Syntax randomised trial, the corelab reproducibility, the potential difference in score assessment between the investigator and the corelab, and to ascertain the impact on one-year outcome after either percutaneous coronary intervention (PCI) or coronary artery bypass surgery (CABG) in patients with complex coronary artery disease. Methods and results: To assess the reliability of Syntax™ scoring, 100 diagnostic angiograms from the Syntax trial were randomly selected and assessed independently by two observers. Intra-observer variability was assessed by analysing 91 sets of angiograms after an interval of at least eight weeks by one of the observers. Clinical outcomes in the randomised cohort of the Syntax trial up to one year are presented with stratification by tertile group of the SYNTAX™ score. The weighted kappa value for the inter-observer reproducibility on the global score was 0.45, while the intra-observer weighted kappa value was 0.59. The SYNTAX™ score as calculated by investigators consistently underscored the corelab score by 3.4 points. When the Syntax randomised cohort was stratified by tertiles of the SYNTAX™ score, there were similar or nonsignificantly different MACCE rates in those with low or intermediate scores; however in the top tertile the MACCE rate was greater in those receiving PCI compared to CABG. Conclusions: The SYNTAX™ score is a visual coronary score with an acceptable corelab reproducibility that has an impact on the one-year outcome of those having PCI, whereas it has no effect on the one-year outcome following surgical revascularisation. The SYNTAX™ score tool is likely to be useful in a wide range of patients with complex coronary disease.
509 citations
••
Cedars-Sinai Medical Center1, Emory University2, Medical City Dallas Hospital3, Columbia University Medical Center4, Cleveland Clinic5, Laval University6, University of Pennsylvania7, MedStar Washington Hospital Center8, University of Missouri–Kansas City9, Washington University in St. Louis10, Mayo Clinic11, Intermountain Medical Center12, Providence St. Vincent Medical Center13, Rutgers University14, New York University15, Primary Children's Hospital16, Scott & White Hospital17, Stanford University18, Columbia University19, Edwards Lifesciences Corporation20
TL;DR: There was no significant difference in the incidence of death or disabling stroke at 5 years after TAVR as compared with surgical aortic-valve replacement among patients with severe, symptomaticAortic stenosis who were at intermediate surgical risk.
Abstract: Background There are scant data on long-term clinical outcomes and bioprosthetic-valve function after transcatheter aortic-valve replacement (TAVR) as compared with surgical aortic-valve r...
441 citations
Authors
Showing all 195 results
Name | H-index | Papers | Citations |
---|---|---|---|
Julio Rosenstock | 94 | 364 | 32784 |
Michael J. Mack | 89 | 519 | 28877 |
Rodney J. Landreneau | 76 | 276 | 22206 |
Glenn M. Preminger | 72 | 505 | 22334 |
David C. Naftel | 67 | 291 | 18814 |
Bartley P. Griffith | 63 | 253 | 14946 |
Yang-Hui He | 57 | 270 | 10347 |
Joseph E. Zerwekh | 50 | 128 | 8592 |
Todd M. Dewey | 45 | 90 | 19069 |
Morley A. Herbert | 44 | 106 | 5397 |
Guo-Wei He | 40 | 191 | 5735 |
Eric J. Eichhorn | 36 | 90 | 6710 |
Rodney J. Landreneau | 36 | 77 | 3960 |
Mitchell J. Magee | 35 | 72 | 3973 |
James R. Edgerton | 35 | 86 | 9495 |